Association Between Statin Medications and COPD-Specific Outcomes: A Real-World Observational Study

BACKGROUND: Disease-modifying drugs are not yet available for the management of chronic obstructive pulmonary disease (COPD). HMG-CoA reductase inhibitors (statins) have anti-inflammatory properties and are therefore being considered for use in the management of COPD. OBJECTIVE: Our objective was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajmera, Mayank, Shen, Chan, Sambamoorthi, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332305/
https://www.ncbi.nlm.nih.gov/pubmed/27943058
http://dx.doi.org/10.1007/s40801-016-0101-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332305/
https://www.ncbi.nlm.nih.gov/pubmed/27943058
http://dx.doi.org/10.1007/s40801-016-0101-6

Ejemplares similares